Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06237465
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-26
First Post:
2024-01-23
Brief Title:
Botulinum Toxin-A for Hidradenitis Suppurativa
Sponsor:
Yale University
Organization:
Yale University
Study Overview
Official Title:
Botulinum Toxin-A for Hidradenitis Suppurativa
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research study is to determine if the medication Botulinum Toxin-A BTX-A is effective in treating hidradenitis suppurativa HS
Detailed Description:
Hidradenitis suppurativa HS is an auto-inflammatory disorder of apocrine sweat glands which results in painful draining nodules within hair-bearing skin of the axillae groin and perineum There is no consensus for treatment of HS and neither a medical nor surgical cure exists Several case reports show potential efficacy of Botulinum Toxin-A BTX-A in inducing remission of HS however these studies are underpowered The objective of this study is to determine if Botulinum Toxin- A induces regression remission or relapse of hidradenitis suppurativa lesions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 000 | OTHER | CTGTY | None |